Yakult Honsha Co.,Ltd.

Tokyo Stock Exchange 2267.T

Yakult Honsha Co.,Ltd. Price to Earnings Ratio (P/E) on January 14, 2025: 16.40

Yakult Honsha Co.,Ltd. Price to Earnings Ratio (P/E) is 16.40 on January 14, 2025, a -11.27% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Yakult Honsha Co.,Ltd. 52-week high Price to Earnings Ratio (P/E) is 21.19 on September 27, 2024, which is 29.22% above the current Price to Earnings Ratio (P/E).
Yakult Honsha Co.,Ltd. 52-week low Price to Earnings Ratio (P/E) is 15.76 on June 21, 2024, which is -3.85% below the current Price to Earnings Ratio (P/E).
Yakult Honsha Co.,Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is 17.90.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Tokyo Stock Exchange: 2267.T

Yakult Honsha Co.,Ltd.

CEO	Mr. Hiroshi Narita
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	10-30, Kaigan, 1-chome
Employees	29,627
Sector	Consumer Discretionary
Industries Cosmetics Consumer Packaged Goods Food & Beverages Pharmaceuticals

Description

Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as generic anti-cancer agents, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. In addition, the company offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years